✦ LIBER ✦

NOTCH1mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment

✍ Scribed by Bo, Michele Dal; Del Principe, Maria Ilaria; Pozzo, Federico; Ragusa, Dario; Bulian, Pietro; Rossi, Davide; Capelli, Giovanni; Rossi, Francesca Maria; Niscola, Pasquale; Buccisano, Francesco; Bomben, Riccardo; Zucchetto, Antonella; Maurillo, Luca; de Fabritiis, Paolo; Amadori, Sergio; Gaidano, Gianluca; Gattei, Valter; Del Poeta, Giovanni

Book ID: 125344206
Publisher: Springer
Year: 2014
Tongue: English
Weight: 1004 KB
Volume: 93
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-014-2117-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The successful treatment of refractory a

The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia

✍ Gülsüm Emel Pamuk; Burhan Turgut; Muzaffer Demir; Fatma Tezcan; Özden Vural 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

5.44 Consolidation Therapy with Subcutan

5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)

✍ Alain Delmer; Olivier Tournilhac; Stéphane Leprêtre; Bruno Cazin; Pierre Feugier 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 113 KB